ImmuneOncia Therapeutics Plunges More Than 10% in Aftermarket Trading
Predicted impact: Medium
Designation as unfaithful disclosure company was flagged earlier; the aftermarket drop is a market reaction, not new news.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.